23.11.2024

Swiss Medical Network

Onco Day 2024

Recap of Onco Day 2024: Innovation at the service of thoracic cancers

On Saturday 23rd November 2024, Swiss Medical Network organised its third Onco Day at the brand new Genolier Innovation Hub. This annual event brings together leading healthcare specialists to discuss innovations and best practice in cancer care.

This 2024 edition focused on thoracic cancers, a highly topical issue, covering a wide range of subjects such as early detection, advanced treatments and new multidisciplinary approaches for patients suffering from these complex pathologies.

A high-level scientific programme
Throughout the day, renowned experts shared their insights and debated the latest advancements in key areas, including:

Screening and staging of lung cancers: from screening criteria to technological innovations enabling more accurate assessment of pulmonary nodules.
Surgical approaches for early and advanced stages: with discussions on minimally invasive techniques such as VATS and RATS, as well as ERAS protocols aimed at improving post-surgical recovery.
Treatment of rare tumours, including pleural mesothelioma and thymic tumours, for which new therapeutic and surgical perspectives were presented.
Radiotherapy and medical oncology: exploring the latest advances in targeted, personalised and innovative treatments to offer patients ever more effective options.

A space dedicated to medical innovation
The day was also an opportunity to discover the Genolier Innovation Hub, a space designed to foster medical excellence and interdisciplinary collaboration. Participants had the chance to explore this unique space, which stands as a symbol of Swiss Medical Network’s commitment to innovation and cutting-edge care.

A success made possible through exceptional collaboration
Swiss Medical Network would like to warmly thank the speakers, moderators and partners for their valuable contributions, as well as all participants who enriched the discussions with their expertise and commitment.

Onco Day 2024 demonstrated once again the importance of interdisciplinary collaboration in pushing back the frontiers of medicine for the benefit of patients. We are already looking forward to the 2025 edition, which will continue to explore new horizons in the fight against cancer.

Thank you to our sponsors for their support!

AstraZeneca

We are using the power of science to shape the future of the Swiss healthcare system. We are committed to a healthy planet with healthy people.

AstraZeneca Switzerland is the Swiss affiliate of AstraZeneca PLC, a UK-Swedish pharmaceutical company. The company has operated in Switzerland since 1976 and since 1999 has been based in the Canton of Zug.

Our core business is the development and marketing of medicines. Currently, over 230,000 people are under treatment with an AstraZeneca medicinal product in Switzerland. By 2026, we anticipate that over 35 new therapies will receive authorisation. We constantly endeavour to do our part to make the Swiss healthcare system more sustainable, robust and ready to meet the challenges of the future. With this goal in mind, we are working - far beyond the scope of our core business - with various stakeholders.

For more information

Bayer

Bayer has been operating in Switzerland since 1954 and is an important employer. We have three national subsidiaries – Bayer (Schweiz) AG, Bayer Consumer Care AG and Bayer Crop Science Schweiz AG – and a total of three locations. The locations operate on both the local and international markets. In addition to the Swiss business, there are various international Bayer functions in Switzerland.

Basel is home to the international headquarters of the Consumer Health division, the EMEA headquarters of the Crop Science division, the international pharmaceutical hub for oncology, ophthalmology and hematology as well as the marketing and sales operations of the Crop Science division for the Swiss agricultural business.

In Muttenz, Bayer manufactures intermediates for fungicides that are sold worldwide.

The Pharmaceuticals and Consumer Health divisions serve the domestic market from Zurich, where functions such as Marketing and Sales, Clinical Research, Medical Affairs and Regulatory Affairs are based.

Watch the video to discover why some 1,450 employees from more than 60 nations enjoy working at Bayer in Switzerland.

For more information

Bristol Myers Squibb

Bristol Myers Squibb is a differentiated company, led by our unique BioPharma strategy that leverages the reach and resources of a major pharma company paired with the entrepreneurial spirit and agility of a biotech firm. We work every day to deliver innovative medicines for patients with serious and life-threatening diseases.

Each day, our employees around the world work together for patients—it drives everything we do. We are focused on helping millions of patients around the world in disease areas such as oncology, cardiovascular, immunoscience, and fibrosis. Through our Research & Development organization, we have built a sustainable pipeline of potential therapies, and actively partner to access external innovation to broaden and accelerate our work.

For more information

Ewimed

Nous sommes le partenaire de distribution des produits médicaux de la société ewimed GmbH, un fabricant allemand de technologie médicale. L'équipe d'ewimed Switzerland AG est votre interlocuteur en Suisse en matière de drainage en cas d'épanchement pleural ou d'ascite .

Les collaborateurs dévoués d'ewimed Switzerland AG ont construit pendant 10 ans une organisation de vente et de service fiable pour les hôpitaux, les cliniques, les médecins, le personnel soignant et les patients.
Grâce aux propriétés uniques du produit et au service ewimed Switzerland AG, l'utilisation des systèmes de drainage par cathéter est très sûre, simple, rapide et rentable.
La qualité de vie et la liberté de mouvement des patients s'améliorent et les coûts directs et indirects pour les patients, les hôpitaux et le système de santé peuvent être réduits.

Avec des produits pour le drainage et la ponction , ainsi que des accessoires pour drainer l'épanchement pleural ou l'ascite, notre gamme couvre les besoins des patients, des médecins, des hôpitaux et des cliniques.

For more information

Lexington Medical

We are a Boston-based medical device company that manufactures minimally invasive surgical stapling solutions. With the highest standards in design engineering and smart manufacturing, our specialized team is committed to delivering disruptive innovation to surgeons and their patients.

For more information

Medisyn

MEDISYN, formerly SYNLAB, stands for personal contact with our customers. We are pleased to stand for MEDISYN quality with our names and faces:. The customer advisors for technical, material and financial matters, the laboratory managers for medical questions and laboratory-analytical interpretations and the laboratory technicians for support with withdrawal material or repeat prescriptions.

For more information

Viatris

Notre mission est de permettre à chacun dans le monde entier de vivre en meilleure santé à chaque étape de sa vie. Nous y parvenons via trois axes majeurs : l'accès, le leadership et le partenariat.

Nous agissons avec courage et notre positionnement unique est source de stabilité dans un monde où les besoins en matière de santé sont en constante évolution.